EXPERIMENTAL SUBSTANTIATION OF THE USE OF AN ORAL THROMBOLYTIC BASED ON IMMOBILIZED SUBTILISIN AND AN ANTICOAGULANT BASED ON LOW-MOLECULAR-WEIGHT HEPARIN FOR TREATING PULMONARY VASCULAR THROMBOSIS IN COVID-19
Bûlletenʹ medicinskoj nauki